Effect of reduction in brain amyloid levels on change in cognitive and functional decline in randomized clinical trials: An instrumental variable meta‐analysis-Reference-Cited by-同舟云学术

Effect of reduction in brain amyloid levels on change in cognitive and functional decline in randomized clinical trials: An instrumental variable meta‐analysis

Published:2022-08-31 Issue:4 Volume:19 Page:1292-1299
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Pang Menglan¹²^ORCID,Zhu Ling¹²,Gabelle Audrey¹²,Gafson Arie R.¹²,Platt Robert W³,Galvin James E⁴,Krolak‐Salmon Pierre⁵⁶,Rubino Ivana²,de Moor Carl¹²,Belachew Shibeshih¹²,Shen Changyu¹²^ORCID

Affiliation:

1. Biogen Digital Health Biogen Cambridge Massachusetts USA

2. Biogen Cambridge Massachusetts USA

3. Department of Epidemiology Biostatistics, and Occupational Health McGill University Montreal Quebec Canada

4. Department of Neurology Comprehensive Center for Brain Health University of Miami Miller School of Medicine Boca Raton Florida USA

5. Clinical and Research Memory Center of Lyon (CMRR Lyon) Lyon Institute for Aging University Hospital of Lyon (Hospices Civils de Lyon) Lyon France

6. Neuroscience Research Centre of Lyon Inserm Lyon France

Funder

Biogen

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.12768

Reference25 articles.

1. Effect of reductions in amyloid levels on cognitive change in randomized trials: instrumental variable meta-analysis

2. NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease

3. The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics

4. The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

5. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estimated effects of amyloid reduction on cognitive change: A Bayesian update across a range of priors;Alzheimer's & Dementia;2023-10-30

2. Precision medicine analysis of heterogeneity in individual‐level treatment response to amyloid beta removal in early Alzheimer's disease;Alzheimer's & Dementia;2023-10-26

3. The effectiveness and value of lecanemab for early Alzheimer disease: A summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum;Journal of Managed Care & Specialty Pharmacy;2023-09

4. Using Optogenetics to Model Cellular Effects of Alzheimer’s Disease;International Journal of Molecular Sciences;2023-02-21

5. Toward the end of a controversy on the effect of reduction in brain amyloid levels on change in cognitive and functional decline in Alzheimer's disease—Reply to a letter;Alzheimer's & Dementia;2022-11-16